Advertisement

Buy track record

How this insider's open-market purchases have performed
8%
of buys now in profit
1 up · 12 down
Avg return since buy−92.1%
Median return−100.0%
Best trade+1.7%
Worst trade−100.0%
Buys scored13
Average return by holding period — separates good entry timing from riding one long winner
After 1 month +1.0% 8% won · 13 trades
After 3 months −0.1% 0% won · 13 trades
After 6 months +0.0% 0% won · 12 trades
After 12 months +0.0% 0% won · 12 trades
DateCompany90d trendBuy priceValueΔOwn1M3M6M12MTo date
Mar 2, 2026 GENB $16 $25M NEW +13.0% −1.6% +1.7%
Jan 30, 2013 BGMD $2 $500K +11% +0.0% +0.0% +0.0% +0.0% −100.0%
Jan 30, 2013 BGMD $2 $250K +24% +0.0% +0.0% +0.0% +0.0% −100.0%
Jan 30, 2013 BGMD $2 $150K +54% +0.0% +0.0% +0.0% +0.0% −100.0%
Jan 30, 2013 BGMD $2 $1M +21% +0.0% +0.0% +0.0% +0.0% −100.0%
Jan 30, 2013 BGMD $2 $2.1M +147% +0.0% +0.0% +0.0% +0.0% −100.0%
Feb 9, 2011 BGMD $7 $250K +7.3% +0.0% +0.0% +0.0% +0.0% −100.0%
Feb 9, 2011 BGMD $7 $75K +3.7% +0.0% +0.0% +0.0% +0.0% −100.0%
Feb 9, 2011 BGMD $7 $150K +30% +0.0% +0.0% +0.0% +0.0% −100.0%
Feb 9, 2011 BGMD $7 $100K +11% +0.0% +0.0% +0.0% +0.0% −100.0%
Feb 9, 2011 BGMD $7 $1.9M +13% +0.0% +0.0% +0.0% +0.0% −100.0%
Feb 9, 2011 BGMD $7 $300K +2.0% +0.0% +0.0% +0.0% +0.0% −100.0%
Feb 9, 2011 BGMD $7 $5M NEW +0.0% +0.0% +0.0% +0.0% −100.0%
How this is calculated. We score only open-market purchases (SEC code P) — the buys that carry real signal. Each trade's return is measured from the adjusted closing price on the purchase date to the latest close, accounting for stock splits and dividends. The 1M/3M/6M/12M columns show the same trade's return after each fixed holding period; a dash means that horizon hasn't elapsed yet or isn't priceable. Sales are excluded because insiders sell for many routine reasons. With only 13 scored trades, treat this as a small sample, not a verdict.
Advertisement
Open-market buys
$36.78M
13 trades
Open-market sells
$106.91M
166 trades
Net flow
−$70.14M
Net selling
Total filings
183
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 28, 2024 ΔOwn −0.1%

Afeyan Noubar sold $184.8K of MRNA.

−$184.8K
1,435 sh @ $129
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 28, 2024 ΔOwn −0.1%

Afeyan Noubar sold $298.6K of MRNA.

−$298.6K
2,300 sh @ $130
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 28, 2024 ΔOwn −0.1%

Afeyan Noubar sold $353.7K of MRNA.

−$353.7K
2,705 sh @ $131
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 28, 2024

Afeyan Noubar sold $92.1K of MRNA.

−$92.1K
700 sh @ $132
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 28, 2024

Afeyan Noubar sold $13.4K of MRNA.

−$13.4K
100 sh @ $134
Advertisement
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 21, 2024 ΔOwn −0.1%

Afeyan Noubar sold $224.8K of MRNA.

−$224.8K
1,700 sh @ $132
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 21, 2024 ΔOwn −0.3%

Afeyan Noubar sold $820.9K of MRNA.

−$820.9K
6,160 sh @ $133
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 21, 2024 ΔOwn −0.3%

Afeyan Noubar sold $917.2K of MRNA.

−$917.2K
6,840 sh @ $134
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 21, 2024

Afeyan Noubar sold $27K of MRNA.

−$27K
200 sh @ $135
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 21, 2024

Afeyan Noubar sold $13.7K of MRNA.

−$13.7K
100 sh @ $137
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 14, 2024

Afeyan Noubar sold $100.1K of MRNA.

−$100.1K
700 sh @ $143
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 14, 2024

Afeyan Noubar sold $58.9K of MRNA.

−$58.9K
408 sh @ $144
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 14, 2024 ΔOwn −0.1%

Afeyan Noubar sold $183.9K of MRNA.

−$183.9K
1,263 sh @ $146
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 14, 2024 ΔOwn −0.1%

Afeyan Noubar sold $444.2K of MRNA.

−$444.2K
3,031 sh @ $147
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 14, 2024 ΔOwn −0.3%

Afeyan Noubar sold $943.9K of MRNA.

−$943.9K
6,397 sh @ $148
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 14, 2024 ΔOwn −0.1%

Afeyan Noubar sold $237.9K of MRNA.

−$237.9K
1,601 sh @ $149
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 14, 2024 ΔOwn −0.1%

Afeyan Noubar sold $209.1K of MRNA.

−$209.1K
1,400 sh @ $149
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 14, 2024

Afeyan Noubar sold $30K of MRNA.

−$30K
200 sh @ $150
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 11, 2024 ΔOwn −2.0%

Afeyan Noubar sold $24.27M of MRNA, trimming their stake 2%.

−$24.27M
163,649 sh @ $148
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 11, 2024 ΔOwn −2.0%

Afeyan Noubar sold $4.68M of MRNA, trimming their stake 2%.

−$4.68M
31,531 sh @ $148
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 11, 2024 ΔOwn −0.1%

Afeyan Noubar sold $959.2K of MRNA.

−$959.2K
6,420 sh @ $149
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 11, 2024 ΔOwn −0.1%

Afeyan Noubar sold $184.1K of MRNA.

−$184.1K
1,232 sh @ $149
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 7, 2024

Afeyan Noubar sold $131.3K of MRNA.

−$131.3K
900 sh @ $146
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 7, 2024

Afeyan Noubar sold $103.4K of MRNA.

−$103.4K
700 sh @ $148
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 7, 2024 ΔOwn −0.1%

Afeyan Noubar sold $267.4K of MRNA.

−$267.4K
1,800 sh @ $149
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 7, 2024

Afeyan Noubar sold $44.8K of MRNA.

−$44.8K
300 sh @ $149
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 7, 2024 ΔOwn −0.1%

Afeyan Noubar sold $429K of MRNA.

−$429K
2,840 sh @ $151
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 7, 2024 ΔOwn −0.2%

Afeyan Noubar sold $592.2K of MRNA.

−$592.2K
3,902 sh @ $152
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 7, 2024 ΔOwn −0.1%

Afeyan Noubar sold $372.6K of MRNA.

−$372.6K
2,437 sh @ $153
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Jun 7, 2024

Afeyan Noubar sold $61.5K of MRNA.

−$61.5K
400 sh @ $154

Frequently asked questions

How is AFEYAN NOUBAR's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from AFEYAN NOUBAR's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.